食管癌干细胞特性及相关蛋白的研究进展

doi:10.3969/j.issn.1004-616x.2023.03.013

[1] UHLENHOPP D J, THEN E O, SUNKARA T, et al. Epidemiology of esophageal cancer:update in global trends, etiology and risk factors[J]. Clin J Gastroenterol, 2020, 13(6):1010-1021.
[2] 刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2):1-13.
[3] 郑鑫林, 夏学阳, 张金周, 等. 食管癌干细胞相关标记物及其分离和鉴定的研究进展[J]. 癌变·畸变·突变, 2016, 28(3):246-248.
[4] MARIE-EGYPTIENNE D T, LOHSE I, HILL R P. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance:potential role of hypoxia[J]. Cancer Lett, 2013, 341(1):63-72.
[5] QIAN X, TAN C, WANG F, et al. Esophageal cancer stem cells and implications for future therapeutics[J]. Onco Targets Ther, 2016, 9:2247-2254.
[6] ROBEY R W, POLGAR O, DEEKEN J, et al. ABCG2:determining its relevance in clinical drug resistance[J]. Cancer Metastasis Rev, 2007, 26(1):39-57.
[7] ROSS D D, NAKANISHI T. Impact of breast cancer resistance protein on cancer treatment outcomes[J]. Methods Mol Biol, 2010, 596:251-290.
[8] WANG D, PLUKKER J T M, COPPES R P. Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer[J]. Semin Cancer Biol, 2017, 44:60-66.
[9] HUANG L J, LU Q, HAN Y, et al. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells[J]. Diagn Pathol, 2012, 7:180.
[10] TENG Y, YU X Y, YUAN H, et al. DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells[J]. Oncotarget, 2018, 9(27):18896-18907.
[11] 滕颖. 食管癌干细胞DNA甲基化谱及相关基因DNMT1功能的研究[D]. 北京:北京协和医学院, 2017.
[12] HONEYWELL R J, SARKISJAN D, KRISTENSEN M H, et al. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors[J]. Nucleic Acids, 2018, 37(12):696-708.
[13] ARNOUK H, YUM G, SHAH D. Cripto-1 as a key factor in tumor progression, epithelial to mesenchymal transition and cancer stem cells[J]. Int J Mol Sci, 2021, 22(17):9280.
[14] ARBORETTO P, CILLO M, LEONARDI A. New insights into cancer targeted therapy:nodal and cripto-1 as attractive candidates[J]. Int J Mol Sci, 2021, 22(15):7838.
[15] XU C H, ZOU J, LI L, et al. Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer[J]. FASEB Bioadv, 2022, 4(8):539-546.
[16] LIU Q, CUI X, YU X, et al. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma[J]. Mol Cancer, 2017, 16(1):81.
[17] 宋爽, 徐琳琳. 表面标志物Cripto-1表达对食管癌干细胞生长的作用机制研究[J]. 蚌埠医学院学报, 2017, 42(10):1313-1317.
[18] DANIEL S K, SEO Y D, PILLARISETTY V G. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies[J]. Semin Cancer Biol, 2020, 65:176-188.
[19] WU X X, ZHANG H D, SUI Z L, et al. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma[J]. Cancer Biol Med, 2021, 18(2):401-410.
[20] WANG X W, CAO Y, ZHANG S R, et al. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer[J]. Oncotarget, 2017, 8(22):36149-36160.
[21] SONG S M, AJANI J A, HONJO S, et al. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties[J]. Cancer Res, 2014, 74(15):4170-4182.
[22] WEI H L, WANG F H, WANG Y, et al. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex[J]. Cancer Sci, 2017, 108(3):478-487.
[23] WANG L H, ZHANG Z Y, YU X D, et al. Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma[J]. Oncogene, 2019, 38(12):2042-2055.
[24] CLOOS P A, CHRISTENSEN J, AGGER K, et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3[J]. Nature, 2006, 442(7100):307-311.
[25] 贾瑞诺. 组蛋白去甲基化酶GASC1维持食管癌肿瘤干细胞及其抑制剂抗肿瘤分子机制研究[D]. 郑州:郑州大学, 2019.
[26] JIA R N, YANG L, YUAN X, et al. GASC1 promotes stemness of esophageal squamous cell carcinoma via NOTCH1 promoter demethylation[J]. J Oncol, 2019, 2019:1621054.
[27] KALLURI R, WEINBERG R A. The basics of epithelial-mesenchymal transition[J]. J Clin Invest, 2009, 119(6):1420-1428.
[28] THIERY J P. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2(6):442-454.
[29] LIU X J, HE M J, LI L L, et al. EMT and cancer cell stemness associated with chemotherapeutic resistance in esophageal cancer[J]. Front Oncol, 2021, 11:672222.
[30] SCHATTON T, FRANK M H. Cancer stem cells and human malignant melanoma[J]. Pigment Cell Melanoma Res, 2008, 21(1):39-55.
[31] 刘灵. 缺氧在食管鳞癌细胞上皮-间质转化及干细胞化中的作用[D]. 郑州:郑州大学, 2015.
[32] FLEMING H E, JANZEN V, CELSO C L, et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo[J]. Cell Stem Cell, 2008, 2(3):274-283.
[33] CHEN Y L, LI D, WANG D P, et al. Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells[J]. J Cell Biochem, 2012, 113(12):3643-3652.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	FENG Dan, FAN Zhilu, WANG Yinong, LI Sai, GUO Jing, CAI Yan, ZHANG Yu, WEI Wenqiang, WANG Mingrong, HAO Jiajie. P4HA2 promotes proliferation of esophageal squamous carcinoma cells via activating the EGFR/AKT/S6 signaling pathway [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(2): 87-94,101.
[2]	LI Ziyao, ZHANG Haiping, MADINIYET·Niyaz, JULATI·Ainiwaer, ZHANG Liwei, EDRIS·Awut. Clinicopathological significance of cystatin 6 protein expression in Kazakh esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(6): 429-433,438.
[3]	WANG Ting, ZHANG Wenwen, ZHANG Yongxin, ZENG Yong, WANG Junling, LI Chengyun. A case-control study on expression of miR-101 cluster and risk of esophageal carcinomas [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(4): 273-278.
[4]	ZHANG Yuling, LIU Ditian, CHEN Chunfa. Impact of CD68 macrophage infiltration on prognosis in primary small cell esophageal carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(4): 279-283.
[5]	YANG Xingxiao, ZHANG Xueyuan, ZOU Naiyi, SHAN Bao'en, MA Ming, ZHU Shuchai. Effects of HMGB1 silencing on migration, invasion and radiosensitivity of esophageal squamous cell carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 327-333.
[6]	CHANG Chen, YANG Liyan, CAI Hongqing, YUAN Qing, HAO Jiajie, WANG Mingrong. Expressions and clinical implications of SERPINE1 mRNA in esophageal squamous carcinoma tissues [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 245-249.
[7]	ZHENG Junwen, CHANG Chen, HAO Jiajie, CAI Yan, WANG Mingrong, ZHANG Yu. Investigation on expression and function of NEDD4 in esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 203-207,224.
[8]	JIAO Wenjing, GUO Xiujuan, SHAO Junguo, JIAO Wenpeng, ZHANG Jinyan. Relationships among blood cell ratios, clinicopathological characteristics and prognosis in esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 213-217.
[9]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 241-245.
[10]	ZHANG Na, FAN Zhilu, YANG Liyan, CHANG Chen, CAI Yan, HAO Jiajie, WANG Mingrong. Clinical significance of decreased SERPINB5 expression in esophageal squamous cell carcinomas [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 101-109.
[11]	JIAO Wenjing, GUO Xiujuan, MA Ming, SHAO Junguo, ZHANG Jinyan. Comparative efficacies between concurrent chemo-radiotherapy and radiotherapy alone in elderly patients with locally advanced esophageal cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 124-128.
[12]	CHEN Wanxian, WANG Simeng, CHEN Zhangyu, WANG Panji, ZHENG Chunwen, LI Enmin, XU Liyan. CASIN, a CDC42 inhibitor, inhibited viability and migration of esophageal carcinoma cells in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 136-142.
[13]	GUO Xiujuan, DU Yanyan, YAN Xi, ZHAO Xuetao, HAN Lina, WU Yipeng, WANG Xuexiao, MA Ming. Expression and clinical significance of CREB in esophageal squamous cell carcinoma tissues [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 387-390,394.
[14]	YANG Xingxiao, ZHANG Xueyuan, ZOU Naiyi, SHAN Bao'en, MA Ming, ZHU Shuchai. Effect of HMGB1 silencing by siRNA on radiosensitivity of esophageal carcinoma KYSE30 cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 269-274.
[15]	YANG Li, ZHANG Mengxian, ZHANG Wei, XIONG Yingyou, CHEN Shiyong, FANG Chengxiang. Data mining to investigate expression and significance of aurora kinase A in esophageal carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 221-228.